Number of the records: 1
Lenalidomide treatment in lower risk myelodysplastic syndromes-The experience of a Czech hematology center. (Positive effect of erythropoietin +/- prednisone addition to lenalidomide in refractory or relapsed patients)
- 1.
SYSNO 0506807 Title Lenalidomide treatment in lower risk myelodysplastic syndromes-The experience of a Czech hematology center. (Positive effect of erythropoietin +/- prednisone addition to lenalidomide in refractory or relapsed patients) Author(s) Jonasova, A. (CZ)
Neuwirtová, R. (CZ)
Polackova, H. (CZ)
Šišková, M. (CZ)
Stopka, T. (CZ)
Cmunt, E. (CZ)
Belickova, M. (CZ)
Moudrá, Alena (UMG-J) [48]
Minařík, L. (CZ)
Fuchs, O. (CZ)
Michalová, K. (CZ)
Zemanová, Z. (CZ)Source Title Leukemia Research. Roč. 69, June (2018), s. 12-17. - : Elsevier Document Type Článek v odborném periodiku Institutional support UMG-J - RVO:68378050 Language eng Country GB Keywords Myelodysplastic syndromes * Lenalidomide * Del(5q) aberration * Erythropoietin * Prednisone URL https://www.sciencedirect.com/science/article/abs/pii/S0145212618300778?via%3Dihub Permanent Link http://hdl.handle.net/11104/0297965
Number of the records: 1